-
1
-
-
57149122878
-
Formulation, release characteristics and bioavailability study of oral monolithic matrix tablets containing carbamazepine
-
N.S. Barakat, I.M. Elbgory, and A.S. Almurshedi Formulation, release characteristics and bioavailability study of oral monolithic matrix tablets containing carbamazepine AAPS. PharmSciTech 9 2008 931 938
-
(2008)
AAPS. PharmSciTech
, vol.9
, pp. 931-938
-
-
Barakat, N.S.1
Elbgory, I.M.2
Almurshedi, A.S.3
-
2
-
-
0017946933
-
Clinical pharmacokinetics of carbamazepine
-
L. Bertilsson Clinical pharmacokinetics of carbamazepine Clin. Pharmacokinet. 3 1978 128 143
-
(1978)
Clin. Pharmacokinet.
, vol.3
, pp. 128-143
-
-
Bertilsson, L.1
-
3
-
-
85047693676
-
Oral pharmacokinetics of carbamazepine in dogs from commercial tablets and a cyclodextrin complex
-
DOI 10.1002/jps.2600821016
-
C.J. Betlach, M.A. Gonzales, B.C. McKiernan, C. Neff-Davis, and N. Bodor Oral pharmacokinetics of carbamazepine in dogs from commercial tablets and a cyclodextrin complex J. Pharm. Sci. 82 1993 1058 1060 (Pubitemid 23314113)
-
(1993)
Journal of Pharmaceutical Sciences
, vol.82
, Issue.10
, pp. 1058-1060
-
-
Betlach, C.J.1
Gonzalez, M.A.2
McKiernan, B.C.3
Neff-Davis, C.4
Bodor, N.5
-
4
-
-
0025810218
-
Development of aqueous parenteral formulations for carbamazepine through the use of modified chclodextrins
-
M.E. Brewster, W.R. Anderson, K.S. Estes, and N. Bodor Development of aqueous parenteral formulations for carbamazepine through the use of modified chclodextrins J. Pharm. Sci. 80 1991 380 383
-
(1991)
J. Pharm. Sci.
, vol.80
, pp. 380-383
-
-
Brewster, M.E.1
Anderson, W.R.2
Estes, K.S.3
Bodor, N.4
-
5
-
-
15444352072
-
Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl- β-cyclodextrin-based formulation of carbamazepine in the dog: Comparison with commercially available tablets and suspensions
-
DOI 10.1021/js9602913
-
M.E. Brewster, W.R. Anderson, D. Meinsma, D. Moreno, A.I. Webb, L. Pablo, K.S. Eses, H. Derendorf, N. Bodor, R. Swchuk, B. Cheung, and E. Pop Intravenous and oral pharmacokinetics evaluation of a 2-hydroxypropyl-β-cyclodextrin- based formulation of carbamazepine in dog: comparison with commercially available tablets and suspensions J. Pharm. Sci. 86 1997 335 339 (Pubitemid 27113768)
-
(1997)
Journal of Pharmaceutical Sciences
, vol.86
, Issue.3
, pp. 335-339
-
-
Brewster, M.E.1
Anderson, W.R.2
Meinsma, D.3
Moreno, D.4
Webb, A.I.5
Pablo, L.6
Estes, K.S.7
Derendorf, H.8
Bodor, N.9
Sawchuk, R.10
Cheung, B.11
Pop, E.12
-
6
-
-
79955000208
-
-
Chinese Pharmacopoeia, 2010. The Pharmacopoeia of the People's Republic of China, vol. 2, pp. 126-127.
-
Chinese Pharmacopoeia, 2010. The Pharmacopoeia of the People's Republic of China, vol. 2, pp. 126-127.
-
-
-
-
7
-
-
0026672498
-
Improvement of oral bioavailability of carbamazepine by inclusion in 2-hydroxypropyl-β-cyclodextrin
-
S. Choudhury, and K.F. Nelson Improvement of oral bioavailability of carbamazepine by inclusion in 2-hydroxypropyl-β-cyclodextrin Int. J. Pharm. 85 1992 175 180
-
(1992)
Int. J. Pharm.
, vol.85
, pp. 175-180
-
-
Choudhury, S.1
Nelson, K.F.2
-
8
-
-
56749173508
-
Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers
-
M. Cirri, M.F. Righi, F. Maestrelli, P. Mura, and M. Valleri Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers Drug Dev. Ind. Pharm. 35 2009 73 82
-
(2009)
Drug Dev. Ind. Pharm.
, vol.35
, pp. 73-82
-
-
Cirri, M.1
Righi, M.F.2
Maestrelli, F.3
Mura, P.4
Valleri, M.5
-
9
-
-
0036857995
-
Preparation, pharmacokinetic and pharmacodynamic evaluation of carbamazepine inclusion complexes with cyclodextrins
-
G.A. El-Gindy, F.A. Mohammed, and S.Y. Salem Preparation, pharmacokinetic and pharmacodynamic evaluation of carbamazepine inclusion complexes with cyclodextrins STP Pharma Sci. 12 2002 369 378 (Pubitemid 35407912)
-
(2002)
S.T.P. Pharma Sciences
, vol.12
, Issue.6
, pp. 369-378
-
-
El-Gindy, G.A.1
Mohammed, F.A.2
Salem, S.Y.3
-
10
-
-
0035181066
-
Effect of water-soluble polymers on naproxen complexation with natural and chemically-modified-β-cyclodextrins
-
M.T. Faucci, and P. Mura Effect of water-soluble polymers on naproxen complexation with natural and chemically-modified-β-cyclodextrins Drug Dev. Ind. Pharm. 27 2001 311 319
-
(2001)
Drug Dev. Ind. Pharm.
, vol.27
, pp. 311-319
-
-
Faucci, M.T.1
Mura, P.2
-
11
-
-
21844459973
-
2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review
-
S. Gould, and R.C. Scott 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): a toxicology review Food Chem. Toxicol. 43 2005 1451 1459
-
(2005)
Food Chem. Toxicol.
, vol.43
, pp. 1451-1459
-
-
Gould, S.1
Scott, R.C.2
-
12
-
-
1442333455
-
Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation
-
DOI 10.1016/j.ejps.2003.11.009, PII S0928098703003294
-
Zhonggui He, Dafang Zhong, Xiaoyan Chen, Xiaohong Liu, Xing Tang, and Limei Zhao Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation Eur. J. Pharm. 21 2004 487 491 (Pubitemid 38283922)
-
(2004)
European Journal of Pharmaceutical Sciences
, vol.21
, Issue.4
, pp. 487-491
-
-
He, Z.1
Zhong, D.2
Chen, X.3
Liu, X.4
Tang, X.5
Zhao, L.6
-
14
-
-
0032526833
-
Enhancement of carbamazepine dissolution: In vitro and in vivo evaluation
-
El-Zein Hind, Riad Lillian, and El-Bary Ahmed Abd Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation Int. J. Pharm. 168 1998 209 220
-
(1998)
Int. J. Pharm.
, vol.168
, pp. 209-220
-
-
Hind, E.-Z.1
Lillian, R.2
Ahmed Abd, E.-B.3
-
15
-
-
0027202722
-
Increase in temperature enhances solubility of drugs in aqueous solutions of hydroxypropylcyclodextrins
-
T. Hoshino, K. Uekama, and J. Pitha Increase in temperature enhances solubility of drugs in aqueous solutions of hydroxypropyl cyclodextrins Int. J. Pharm. 98 1993 239 242 (Pubitemid 23242413)
-
(1993)
International Journal of Pharmaceutics
, vol.98
, Issue.1-3
, pp. 239-242
-
-
Hoshino, T.1
Uekama, K.2
Pitha, J.3
-
16
-
-
0031054513
-
Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation
-
DOI 10.1021/js960213f
-
T. Irie, and K. Uekama Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation J. Pharm. Sci. 86 1997 147 162 (Pubitemid 27078377)
-
(1997)
Journal of Pharmaceutical Sciences
, vol.86
, Issue.2
, pp. 147-162
-
-
Irie, T.1
Uekama, K.2
-
17
-
-
0031750464
-
Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose
-
DOI 10.1016/S0168-3659(98)00002-9, PII S0168365998000029
-
I. Katzhendler, R. Azoury, and M. Friedman Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose J. Control. Release 54 1998 69 85 (Pubitemid 28255239)
-
(1998)
Journal of Controlled Release
, vol.54
, Issue.1
, pp. 69-85
-
-
Katzhendler, I.1
Azoury, R.2
Friedman, M.3
-
18
-
-
2442643153
-
Bioavailability of carbamazepine:β-cyclodextrin complex in beagle dogs from hydroxypropylmethylcellulose matrix tablets
-
DOI 10.1016/j.ejps.2004.03.010, PII S0928098704000752
-
L.S. Koester, J.B. Bertuol, K.R. Groch, C.R. Xavier, R. Moellerke, P. Mayorga, T. Dalla Costa, and V.L. Bassani Bioavailability of carbamazepine: β-cyclodextrin complex in beagle dogs from hydroxylpropylmethylcellulose matrix tablets Eur. J.Pharm. Sci. 22 2004 201 207 (Pubitemid 38668685)
-
(2004)
European Journal of Pharmaceutical Sciences
, vol.22
, Issue.2-3
, pp. 201-207
-
-
Koester, L.S.1
Bertuol, J.B.2
Groch, K.R.3
Xavier, C.R.4
Moellerke, R.5
Mayorga, P.6
Dalla Costa, T.7
Bassani, V.L.8
-
19
-
-
79955021839
-
Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets
-
L.S. Koester, C.R. Xavier, P. Mayorga, and V.L. Bassani Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets Eur. J. Pharm. Biopharm. 60 2003 73 80
-
(2003)
Eur. J. Pharm. Biopharm.
, vol.60
, pp. 73-80
-
-
Koester, L.S.1
Xavier, C.R.2
Mayorga, P.3
Bassani, V.L.4
-
20
-
-
0034601240
-
Improving drug solubility for oral delivery using solid dispersions
-
DOI 10.1016/S0939-6411(00)00076-X, PII S093964110000076X
-
C. Leuner, and J. Dressman Improving drug solubility for oral delivery using solid dispersions Eur. J. Pharm. Biopharm. 50 2000 47 60 (Pubitemid 30326688)
-
(2000)
European Journal of Pharmaceutics and Biopharmaceutics
, vol.50
, Issue.1
, pp. 47-60
-
-
Leuner, C.1
Dressman, J.2
-
21
-
-
0344588867
-
The effect of water-soluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin
-
DOI 10.1016/S0378-5173(97)00371-2, PII S0378517397003712
-
T. Loftsson, and H. Fririksdóttir The effect of water-soluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin Int. J. Pharm. 163 1998 115 121 (Pubitemid 28162625)
-
(1998)
International Journal of Pharmaceutics
, vol.163
, Issue.1-2
, pp. 115-121
-
-
Loftsson, T.1
Fririksdottir, H.2
-
23
-
-
0004144140
-
-
28th ed. The Pharmaceutical Press London
-
Martindale The Extra Pharmacopoeia 28th ed. 1982 The Pharmaceutical Press London
-
(1982)
The Extra Pharmacopoeia
-
-
Martindale1
-
24
-
-
0029852699
-
Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery
-
DOI 10.1021/js960075u
-
R.A. Rajewski, and V.J. Stella Pharmaceutical applications of cyclodextrins, II: in vivo drug delivery J.Pharm. Sci. 85 1996 1142 1169 (Pubitemid 26372882)
-
(1996)
Journal of Pharmaceutical Sciences
, vol.85
, Issue.11
, pp. 1142-1169
-
-
Rajewski, R.A.1
Stella, V.J.2
-
25
-
-
17444415305
-
Effect of SBE7-β-cyclodextrin complexation on carbamazepine release from sustained release beads
-
DOI 10.1016/j.ejpb.2004.12.001
-
J.S. Smith, R.J. MacRae, and M.J. Snowden Effect of SBE-β- cyclodextrin complexation on carbamazepine release from sustained release beads Eur. J. Pharm. Biopharm. 60 2005 73 80 (Pubitemid 40545863)
-
(2005)
European Journal of Pharmaceutics and Biopharmaceutics
, vol.60
, Issue.1
, pp. 73-80
-
-
Smith, J.S.1
MacRae, R.J.2
Snowden, M.J.3
-
26
-
-
0031042310
-
Cyclodextrins - enabling excipients: Their present and future use in pharmaceuticals
-
D.O. Thompson Cyclodextrins-enabling excipients: their present and future use in Pharmaceuticals Crit. Rev. Ther. Drug Carrier Syst. 14 1997 1 104 (Pubitemid 27079973)
-
(1997)
Critical Reviews in Therapeutic Drug Carrier Systems
, vol.14
, Issue.1
, pp. 1-104
-
-
Thompson, D.O.1
|